Correction: Invitrogen Suit Against GE Healthcare Transferred to Texas | GenomeWeb

Correction: This article has been corrected to relect that this is not a new suit, but rather a lawsuit that is a couple of years old that was transferred from Maryland to Texas. Court documents did not disclose that the suit was transferred, but rather was listed as a new filing.

NEW YORK (GenomeWeb News) – A lawsuit that Invitrogen, a division of Life Technologies, filed against GE Healthcare a couple of years ago alleging infringement of several patents held by Invitrogen has been transferred to a Texas court from Maryland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.